Copertina

Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	E. S. Hoogeveen, N. Pelzer, E. Ghariq, M. J. P. van Osch, A. Dahan, G. M. Terwindt, M. C. Kruit
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Substance use in a Dutch migraine cohort compared with the general population
di: Thomas C. van den Hoek, et al.
Pubblicazione: (2024)

Useful considerations for treating migraine in patients with autism
di: Sinifunanya E. Nwaobi
Pubblicazione: (2026)

A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine
di: Ye Su, et al.
Pubblicazione: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
di: Chia‐Chun Chiang, et al.
Pubblicazione: (2024)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
di: Kara S. Graves, et al.
Pubblicazione: (2026)

Cardiovascular risk and triptan usage among patients with migraine
di: Ido Peles, et al.
Pubblicazione: (2025)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
di: Jessica Ailani, et al.
Pubblicazione: (2026)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
di: Antonio Munafò, et al.
Pubblicazione: (2026)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
di: David Kudrow, et al.
Pubblicazione: (2025)

Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine
di: Jeanne Rossignol, et al.
Pubblicazione: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
di: Susan Hutchinson, et al.
Pubblicazione: (2026)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
di: Andrea M. Kuczynski, et al.
Pubblicazione: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
di: Iyas Daghlas, et al.
Pubblicazione: (2024)

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models
di: Gina M. Dumkrieger, et al.
Pubblicazione: (2024)

Heavy metal and trace element alterations in patients during a migraine attack
di: Sevilay Vural, et al.
Pubblicazione: (2024)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
di: Lawrence C. Newman, et al.
Pubblicazione: (2025)

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine
di: Chay Ngee Lim, et al.
Pubblicazione: (2025)

Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
di: Stephen Silberstein, et al.
Pubblicazione: (2026)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
di: M. Ismail K. Yousaf, et al.
Pubblicazione: (2025)

Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
di: Seonyoung Kang, et al.
Pubblicazione: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
di: Andrew Blumenfeld, et al.
Pubblicazione: (2024)

Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation
di: Vishwesh Vishnu Naik, et al.
Pubblicazione: (2025)

Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine
di: Yukihisa Suzuki, et al.
Pubblicazione: (2024)

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study
di: Jessica Ailani, et al.
Pubblicazione: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

Prevalence and burden of migraine in the United States: A systematic review
di: Fred Cohen, et al.
Pubblicazione: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
di: Bilal Ahmed Rizvi, et al.
Pubblicazione: (2024)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
di: Keshet Pardo, et al.
Pubblicazione: (2025)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
di: Muneto Tatsumoto, et al.
Pubblicazione: (2024)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
di: Alexander Yoo, et al.
Pubblicazione: (2025)

Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine
di: Haley C. Cropper, et al.
Pubblicazione: (2024)

Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study
di: Richard J. Bertz, et al.
Pubblicazione: (2024)

Higher artificial intelligence‐ ECG atrial fibrillation prediction model output and estimated physiologic aging predict higher risk of adverse vascular events in patients with migraine
di: Ping‐Hao Yang, et al.
Pubblicazione: (2026)

Evaluating associations of migraine‐related vertigo
di: Nazia Karsan, et al.
Pubblicazione: (2025)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
di: Julia Peris‐Subiza, et al.
Pubblicazione: (2025)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
di: Anna de Dios, et al.
Pubblicazione: (2024)

Headache‐related disability as a function of migraine aura: A daily diary study
di: Delora E. Denney, et al.
Pubblicazione: (2024)